FR2370473A1 - Azetidine compsn. for treating psoriasis - contg. 3-hydrocarbyl-sulphonyloxy-azetidine derivs. formulated e.g. as topical compsn. - Google Patents
Azetidine compsn. for treating psoriasis - contg. 3-hydrocarbyl-sulphonyloxy-azetidine derivs. formulated e.g. as topical compsn.Info
- Publication number
- FR2370473A1 FR2370473A1 FR7733934A FR7733934A FR2370473A1 FR 2370473 A1 FR2370473 A1 FR 2370473A1 FR 7733934 A FR7733934 A FR 7733934A FR 7733934 A FR7733934 A FR 7733934A FR 2370473 A1 FR2370473 A1 FR 2370473A1
- Authority
- FR
- France
- Prior art keywords
- azetidine
- compsn
- treating psoriasis
- formulated
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical compsn. contains as active ingredient an azetidine deriv. of formula (I) or its acid addn. salts. In (I) R1 is H, 3-18C alkyl, 5-15C cycloalkyl, 1- or 2-adamantyl, benzylhydryl, benzyl (opt. substd. by 2, same, OH, alkoxy or benzoyloxy), 3-(5 alpha-cholestanyl) or 3-(17-oxy-5 alpha-androstanyl. R2 is 1-18C alkyl, benzyl or tolyl. R3 and R4 are each H or 1-4C alkyl. (I) and their salts are new when R1 is 3-(5 alpha-cholestanyl) or 3-(17-3xy-5 alpha-androstanyl). Also new are the maleate and hemimaleate of 1-isopropyl3-methanesulphonyloxyazetidine (Ia). (I) are used in treating psoriasis and are formulated in conventional topical or sub-cutaneous formulations. The usual dose is 0.1-5 mg/kg/day for treating psoriasis, mycoses or vitiligo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74158276A | 1976-11-12 | 1976-11-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2370473A1 true FR2370473A1 (en) | 1978-06-09 |
Family
ID=24981316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7733934A Withdrawn FR2370473A1 (en) | 1976-11-12 | 1977-11-10 | Azetidine compsn. for treating psoriasis - contg. 3-hydrocarbyl-sulphonyloxy-azetidine derivs. formulated e.g. as topical compsn. |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5363369A (en) |
AU (1) | AU3057577A (en) |
BE (1) | BE860705A (en) |
DE (1) | DE2750300A1 (en) |
FR (1) | FR2370473A1 (en) |
IL (1) | IL53351A0 (en) |
NL (1) | NL7712444A (en) |
NZ (1) | NZ185661A (en) |
ZA (1) | ZA776725B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2649100B1 (en) * | 1989-06-29 | 1994-03-04 | Laboratorios Dr Esteve Sa | NOVEL AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION AS INTERMEDIATES FOR THE PREPARATION OF COMPOUNDS WITH ANTIMICROBIAL ACTIVITY |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2077681A1 (en) * | 1970-02-24 | 1971-11-05 | Takeda Chemical Industries Ltd | N-substd azetidin-3-sulphonates-sedatives - and inters for guanidino-azetidines |
-
1977
- 1977-11-10 IL IL53351A patent/IL53351A0/en unknown
- 1977-11-10 JP JP13522577A patent/JPS5363369A/en active Pending
- 1977-11-10 FR FR7733934A patent/FR2370473A1/en not_active Withdrawn
- 1977-11-10 BE BE182527A patent/BE860705A/en unknown
- 1977-11-10 NZ NZ185661A patent/NZ185661A/en unknown
- 1977-11-10 DE DE19772750300 patent/DE2750300A1/en not_active Withdrawn
- 1977-11-10 ZA ZA00776725A patent/ZA776725B/en unknown
- 1977-11-11 AU AU30575/77A patent/AU3057577A/en active Pending
- 1977-11-11 NL NL7712444A patent/NL7712444A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2077681A1 (en) * | 1970-02-24 | 1971-11-05 | Takeda Chemical Industries Ltd | N-substd azetidin-3-sulphonates-sedatives - and inters for guanidino-azetidines |
Non-Patent Citations (1)
Title |
---|
NCA1972 * |
Also Published As
Publication number | Publication date |
---|---|
BE860705A (en) | 1978-05-10 |
JPS5363369A (en) | 1978-06-06 |
DE2750300A1 (en) | 1978-05-18 |
NL7712444A (en) | 1978-05-17 |
IL53351A0 (en) | 1978-01-31 |
ZA776725B (en) | 1978-09-27 |
AU3057577A (en) | 1979-05-17 |
NZ185661A (en) | 1980-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES482155A1 (en) | Phenethanolamines, their formulations, use and preparation. | |
HUT70426A (en) | Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents | |
MY174339A (en) | 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions | |
AU538424B2 (en) | Piperazino phenylindane | |
DK0414529T3 (en) | Substituted steroid derivatives | |
ES8301878A1 (en) | 1-Phenyl-2-cyclohexene-1-alkylamine derivatives, process for their preparation and medicines containing them. | |
NO873722D0 (en) | NEW DERIVATIVES OF 4,5-DIHYDRO-OXSAZOLES, AND THE PROCEDURE FOR THEIR PREPARATION. | |
ES431497A1 (en) | S-triazolo(1,5-a)pyridine derivative | |
FR2370473A1 (en) | Azetidine compsn. for treating psoriasis - contg. 3-hydrocarbyl-sulphonyloxy-azetidine derivs. formulated e.g. as topical compsn. | |
GB1357449A (en) | Furoquinolinecarboxylic acid derivatives | |
ES8501763A1 (en) | Novel derivative of thienopyridinone, its preparation and its therapeutic use. | |
ES441616A1 (en) | Pharmacologically active anilinobenzothiazoles | |
IE832680L (en) | Nitrosourea derivatives. | |
DE3374005D1 (en) | 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle | |
DE3362725D1 (en) | Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them | |
GB1480025A (en) | Derivatives of pyrazolo-(4,3-c)pyridimes | |
JPS56103183A (en) | Pyridazine derivative and its application to medicine | |
MY106235A (en) | New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them. | |
GB1109588A (en) | Improvements in or relating to nitrothiophene compounds | |
ES8204980A1 (en) | Lidocaine derivative and therapeutic compositions which contain it as their active principle. | |
GB1324676A (en) | Derivatives of 1,7,7-trimethyl-2-norbornane-2-spiro-1,3-dioxolane their process of preparation and their therapeutic application | |
ES445969A1 (en) | Substituted piperazine derivative, its preparation and anorexia compositions containing it | |
ES8205804A1 (en) | Benzopyrano (2,3-d) triazole-derivatives, their preparation and use in pharmaceutical compositions. | |
GB1388146A (en) | Hydroxycrotonic acid derivatives | |
FR2327771A2 (en) | N-Heterocyclylmethy 12-methoxy-benzamides - useful for treating nervous and psychosomatic disorders (BE170676) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |